These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9746244)

  • 21. Purification and characterization of human tissue prokallikrein and kallikrein isoforms expressed in Chinese hamster ovary cells.
    Lu HS; Hsu YR; Narhi LO; Karkare S; Lin FK
    Protein Expr Purif; 1996 Sep; 8(2):227-37. PubMed ID: 8812867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
    Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
    Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contamination of purified prostate-specific antigen preparations by kallikrein hK2.
    Frenette G; Gervais Y; Tremblay RR; Dubé JY
    J Urol; 1998 Apr; 159(4):1375-8. PubMed ID: 9507887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells.
    Saedi MS; Zhu Z; Marker K; Liu RS; Carpenter PM; Rittenhouse H; Mikolajczyk SD
    Int J Cancer; 2001 Nov; 94(4):558-63. PubMed ID: 11745444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.
    Obiezu CV; Soosaipillai A; Jung K; Stephan C; Scorilas A; Howarth DH; Diamandis EP
    Clin Chem; 2002 Aug; 48(8):1232-40. PubMed ID: 12142379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.
    Lövgren J; Rajakoski K; Karp M; Lundwall â ; Lilja H
    Biochem Biophys Res Commun; 1997 Sep; 238(2):549-55. PubMed ID: 9299549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
    Young CY; Seay T; Hogen K; Charlesworth MC; Roche PC; Klee GG; Tindall DJ
    Prostate Suppl; 1996; 7():17-24. PubMed ID: 8950360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2.
    Kumar A; Goel AS; Payne JK; Evans C; Mikolajczyk SD; Kuus-Reichel K; Saedi MS
    Protein Expr Purif; 1999 Feb; 15(1):62-8. PubMed ID: 10024471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.
    Magklara A; Scorilas A; Catalona WJ; Diamandis EP
    Clin Chem; 1999 Nov; 45(11):1960-6. PubMed ID: 10545066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer.
    Lee SW; Hosokawa K; Kim S; Jeong OC; Lilja H; Laurell T; Maeda M
    Sensors (Basel); 2015 May; 15(5):11972-87. PubMed ID: 26007739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies.
    Saedi MS; Cass MM; Goel AS; Grauer L; Hogen KL; Okaneya T; Griffin BY; Klee GG; Young CY; Tindall DJ
    Mol Cell Endocrinol; 1995 Apr; 109(2):237-41. PubMed ID: 7664987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors.
    Lövgren J; Airas K; Lilja H
    Eur J Biochem; 1999 Jun; 262(3):781-9. PubMed ID: 10411640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.
    Mikolajczyk SD; Millar LS; Marker KM; Grauer LS; Goel A; Cass MM; Kumar A; Saedi MS
    Eur J Biochem; 1997 Jun; 246(2):440-6. PubMed ID: 9208936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
    Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
    J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.
    Tremblay RR; Deperthes D; Têtu B; Dubé JY
    Am J Pathol; 1997 Feb; 150(2):455-9. PubMed ID: 9033261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of the alpha form of rat plasma kallikrein.
    Kouyoumdjian M; Borges DR; Michelacci YM; Guimarães JA; Sampaio CA; Prado JL
    Braz J Med Biol Res; 1987; 20(5):549-52. PubMed ID: 3452443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The purification of human urinary kallikrein with ion-exchange radial flow membrane chromatography.
    Wang H; Li T; Zou H; Zhang Y; Chao J; Chao L
    Biomed Chromatogr; 1996; 10(3):139-43. PubMed ID: 8792866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue.
    Herrala AM; Porvari KS; Kyllönen AP; Vihko PT
    Cancer; 2001 Dec; 92(12):2975-84. PubMed ID: 11753974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Western blotting analysis of antibodies to prostate-specific antigen: cross-reactivity with human kallikrein-2.
    Wang TJ; Linton HJ; Rittenhouse HG; Wolfert RL
    Tumour Biol; 1999; 20 Suppl 1():75-8. PubMed ID: 10628412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
    Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.